Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Excerpt from Phoenix Group's website: "The Phoenix Group consists of 29 unique companies operating in 5 distinct verticals"
One of the biggest Crypto player's in the world and they fully control the TCRI shell. They appear to be lining something up, that is clearly evident.
Mark out
Hard to say, but all early indications suggest that TCRI is headed to multiple dollars$$$$$$$$$$$$$$
Mark out
Where you at Mouth?
Mark out
MEGA! Big BIG money backing this ticker.
Mark out
Yes, let's see what is revealed over the next several days/weeks. All indications are suggesting that it might be pretty substantial.
Mark out
Nice read on Mr. Munaf Ali: https://issuu.com/entmagazineme/docs/entrepreneur_middle_east_november_2023
Mark out
New TCRI website in development: https://techcom-inc.com/
Mark out
Excerpt from TCRI LinkedIn page: Company size
51-200 employees
https://www.linkedin.com/company/techcominc/about/
Wonder what that's all about?
Mark out
Excerpt from TCRI LinkedIn page: Company size
51-200 employees
Wonder what that's all about?
Mark out
TCRI 8k out
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Resignation of Directors and Officers
Effective as of November 3, 2023, Mr. Seng Yeap Kok resigned as the Chief Executive Officer, and Director of TechCom Inc. (the “Company”) and Mr. Lau Chew Chye resigned as the Chief Financial Officer, Secretary and Director of the Company.
Appointment of Directors and Officers
Effective as of November 3, 2023, AlphaBit, LLC, the holder of a majority of the issued and outstanding shares of Common Stock of the Company, elected Mr. Sheharyar Haider Malhi and Mr. Carl Stuart Agren as Directors of the Company and accepted the resignations of Mr. Seng Yeap Kok and Mr. Lau Chew Chye.
Effective as of November 3, 2023, the Board of Directors (the “Board”) of the Company appointed Mr. Charles Faulkner to serve as its Chief Executive Officer and Mr. Simon Wajcenberg to serve as its Chief Financial Officer and Secretary.
The Company currently pays no compensation to the new officers and no compensation will be paid so long as the Company has no operations or capital. Compensation will be paid should the Company become an operating company, of which there can be no assurance.
Neither Mr. Agren, Mr. Malhi , Mr. Wajcenberg nor Mr. Faulkner have any family relationships with any director or other executive officer of the Company. There are no transactions between the Company and any of these individuals that are required to be disclosed pursuant to Item 404(a) of Regulation S-K.
Biographical Information
Mr. Carl Stuart Agren, age 47 – From April 2022 through the present, Mr. Agren has served as Chief Executive Officer of Phoenix Group, a company specializing in cryptocurrency and blockchain technology. From May 2018 thought March 2022, he served as Chief Operating Officer of G42 Cloud. The Company believes the Mr. Agren is well suited to be a Director due to his experience in international senior level management and as a company officer. Mr. Agren has a Master of Art, Business Information Systems, from the University of Phoenix and a Bachelor of Science, Business Information Systems from the University of Idaho.
Mr. Sheharyar Haider Malhi, age 41 – From July 2023 through the present, Mr. Malhi has been the Chief Financial Officer of Phoenix Group. From May 2022 through July 2023, he was Chief Financial Officer of AI Group. From March 2022 through May 2022, he was Director of KPMG Norway. From November 2018 through March 2020, he was Chief Financial Officer of AK Jensen. From November 2008 through November 2018, he was Senior Manager at KPMG in Ireland and Norway. The Company believes that Mr. Malhi is well qualified to be a Director due to his extensive senior management and director level roles throughout Europe and the Middle East.
Charles Faulkner, age 38 - Mr. Faulkner has served as Chief Executive Officer of EdgeMode Inc. from March 2020 to present. At EdgeMode, he is responsible for general management of business operations, vision and growth of the business, including corporate development, marketing and strategy. He worked as a director responsible for day to day management of operations at North Block Capital Led. from December 2017 to March 2020. Mr. Faulkner has a Bachelor of Arts with honors from De Montfort University.
Simon Wajcenberg, age 56 - Mr. Wajcenberg has served as the Chairman and Chief Financial Officer, with responsibility for board oversight and financial operations, at EdgeMode Inc. from March 2020 through the present. He served as Chief Executive Officer of North Block Capital Ltd from December 2017 through March 2020. He has served as Chairman of the Board of EdgeMode Inc., a company publicly traded in the United States, from February 2022 to present. Mr. Wajcenberg has passed three A levels in the United Kingdom.
Wow! Things just got very interesting to say the least.
Mark out
Yes, Qin Yang has some really impressive credentials. Looks like he just came on board back in August, perhaps just for the IPO listing. I also am looking forward to those financials here in the next week or two, to see if anything interesting pops up. It still seems logical to me to think that they'll utilize the TCRI at some point to get at the much more liquid U.S. market. I'm especially watching those spot Bitcoin ETF approvals. In time, those will do a tremendous amount of good for the Crypto market as a whole. A lot of institutional investors are waiting on the sidelines to see those come to fruition.
Mark out
Poste, Any thing new found on TCRI lately? They seem to be keeping hush hush on everything so far. Just wondering if you heard or read anything pertaining to The Pheonix Group/TCRI
Mark out
I still think they'll want to get at the US investors somehow, someway. Have to wait and see how they'll utilize the TCRI shell. They're obviously keeping it and paying all the bills for a reason????
https://blog.otcmarkets.com/2022/03/08/otc-is-the-next-frontier-for-european-listed-companies/
Mark out
Nice interview with M2's CEO Stefan Kimmel:
https://www.unlock-bc.com/110218/exclusive-interview-m2-ceo-stefan-kimmel-on-launch-and-uae-crypto-revolution/
Mark out
It has begun. We'll just have to wait and see how the TCRI shell plays into their plans. https://www.linkedin.com/feed/update/urn:li:activity:7118622766882287618/?origin=SHARED_BY_YOUR_PAGES
https://www.phoenixgroupuae.com/
Mark out
It has begun. We'll just have to wait an see how the TCRI shell plays into their plans. https://www.phoenixgroupuae.com/
https://www.linkedin.com/feed/update/urn:li:activity:7118622766882287618/?origin=SHARED_BY_YOUR_PAGES
Mark out
Very interesting stuff happening in the U.A.E. https://www.foxbusiness.com/video/6338085750112
The U.S. better get their head out of their ass or they'll be left behind...........Quick! One hard headed guy holding things back. The U.S. should be leading the way and we're not.
Mark out
Very interesting stuff happening in the U.A.E. https://www.foxbusiness.com/video/6338085750112
The U.S. better get their head out of their ass or they'll be left behind...........Quick! One hard headed guy holding things back. The U.S. should be leading the way and we're not.
Mark out
Yes, don't quit your day job just yet. We'll have to see how things play out with Phoenix holding/controlling this shell. I'm certainly very optimistic here but wait and see none-the-less. Very pleased with "who" is the major shareholder (87%) of the TCRI shell.
Mark out
It's all in the financial filings for TCRI. You just have to know what you're looking for. Here's a clue:https://www.apollo.io/people/Munaf/Ali/606ab23843892a00010e7ad9
Mark out
Excerpt from TCRI's latest filing:
NOTE 4 – DUE TO RELATED PARTY
In the normal business operations, the major shareholder funds the Company’s operation expenses. For the six and three months ended June 30, 2023, the major shareholder paid $48,900 and $16,497, respectively; for the six and three months ended June 30, 2022, the major shareholder paid $51,990 and $15,017, respectively. As of June 30, 2023 and December 31, 2022, the balances of due to shareholder were $163,311 and $114,411, respectively.
Fully SEC reporting and according to their latest filings, they are paying all the shells bills. Apparently, they are planning on doing something with it. Might want to keep an eye out here at the very least!
Mark out
Yes, with the majority shareholder of the TCRI shell being The Phoenix Group/Phoenix Technology
Mark out
The Phoenix Group isn't messing around, full steam ahead: https://www.thenationalnews.com/business/cryptocurrencies/2023/08/24/uaes-phoenix-group-links-up-with-green-data-city-to-start-300m-crypto-farm-in-oman/?utm_source=linkedin&utm_medium=socialsharebtn
Consider this regarding TCRI:
Foreign companies often choose to list on foreign exchanges but trade Over-the-Counter (OTC) in the United States for a variety of reasons, including regulatory, cost, and visibility considerations:
* Regulatory Differences: Listing on a foreign exchange may involve complying with different regulatory requirements and standards. The regulatory landscape in the U.S. can be complex and demanding, which might deter some foreign companies from directly listing on U.S. exchanges. By trading OTC, they can avoid some of the regulatory hurdles associated with a formal U.S. exchange listing.
* Cost Considerations: Listing on major U.S. exchanges like the New York Stock Exchange (NYSE) or NASDAQ can be expensive due to listing fees, compliance costs, legal fees, and ongoing reporting requirements. Trading OTC might offer a more cost-effective way for foreign companies to access U.S. investors without incurring the high costs of a formal exchange listing.
* Market Access: By trading OTC, foreign companies can still gain access to U.S. investors without necessarily having to comply with all the listing requirements of a U.S. exchange. This is particularly attractive for smaller foreign companies that may not meet the stringent criteria for a U.S. exchange listing.
* Liquidity and Visibility: While trading OTC may offer access to U.S. investors, it might not provide the same level of liquidity and visibility as a major U.S. exchange. However, for some foreign companies, the OTC market can still provide a platform to engage with U.S. investors and build brand recognition over time.
* Flexibility: OTC trading can be more flexible in terms of reporting requirements and ongoing obligations. Foreign companies might prefer this flexibility, especially if their reporting and governance practices differ from U.S. standards.
* Timing and Strategy: Some foreign companies might use the OTC market as an initial step to gauge U.S. investor interest before committing to a full exchange listing. It allows them to test the waters and assess market demand without making a significant upfront commitment.
* Dual-Listing Strategy: In some cases, foreign companies might pursue a dual-listing strategy, where they maintain their primary listing on their home exchange and also trade OTC in the U.S. This strategy can offer a compromise between regulatory requirements and market access.
* Risk Perception: Some foreign companies might perceive trading OTC as less risky in terms of compliance and regulatory obligations compared to listing on a major U.S. exchange, which can be seen as a more stringent and closely scrutinized environment.
It's important to note that each company's decision is influenced by its specific circumstances, goals, and market conditions. The choice between listing on a foreign exchange and trading OTC in the U.S. involves a careful consideration of factors such as regulatory complexity, costs, market visibility, and investor preferences.
Consider this regarding TCRI:
Foreign companies often choose to list on foreign exchanges but trade Over-the-Counter (OTC) in the United States for a variety of reasons, including regulatory, cost, and visibility considerations:
* Regulatory Differences: Listing on a foreign exchange may involve complying with different regulatory requirements and standards. The regulatory landscape in the U.S. can be complex and demanding, which might deter some foreign companies from directly listing on U.S. exchanges. By trading OTC, they can avoid some of the regulatory hurdles associated with a formal U.S. exchange listing.
* Cost Considerations: Listing on major U.S. exchanges like the New York Stock Exchange (NYSE) or NASDAQ can be expensive due to listing fees, compliance costs, legal fees, and ongoing reporting requirements. Trading OTC might offer a more cost-effective way for foreign companies to access U.S. investors without incurring the high costs of a formal exchange listing.
* Market Access: By trading OTC, foreign companies can still gain access to U.S. investors without necessarily having to comply with all the listing requirements of a U.S. exchange. This is particularly attractive for smaller foreign companies that may not meet the stringent criteria for a U.S. exchange listing.
* Liquidity and Visibility: While trading OTC may offer access to U.S. investors, it might not provide the same level of liquidity and visibility as a major U.S. exchange. However, for some foreign companies, the OTC market can still provide a platform to engage with U.S. investors and build brand recognition over time.
* Flexibility: OTC trading can be more flexible in terms of reporting requirements and ongoing obligations. Foreign companies might prefer this flexibility, especially if their reporting and governance practices differ from U.S. standards.
* Timing and Strategy: Some foreign companies might use the OTC market as an initial step to gauge U.S. investor interest before committing to a full exchange listing. It allows them to test the waters and assess market demand without making a significant upfront commitment.
* Dual-Listing Strategy: In some cases, foreign companies might pursue a dual-listing strategy, where they maintain their primary listing on their home exchange and also trade OTC in the U.S. This strategy can offer a compromise between regulatory requirements and market access.
* Risk Perception: Some foreign companies might perceive trading OTC as less risky in terms of compliance and regulatory obligations compared to listing on a major U.S. exchange, which can be seen as a more stringent and closely scrutinized environment.
It's important to note that each company's decision is influenced by its specific circumstances, goals, and market conditions. The choice between listing on a foreign exchange and trading OTC in the U.S. involves a careful consideration of factors such as regulatory complexity, costs, market visibility, and investor preferences.
I'm pretty sure that they'll be utilizing the TCRI shell in some capacity. I'm thinking it may end up being tied into this UAE IPO somehow. Why else would they be holding onto it and paying all the bills? I've always believed that they (Phoenix/Munaf/Bijan/other insiders) would want to see a ROI at some point, and what better way than taking things public. Good to have a little insight on what they're thinking at the moment. I also have that M2 thing lingering in the back of my mind as well.
Mark out
Been watching M2 developments closely myself. Interesting indeed. Munaf/Phoenix have been paying all the TCRI bills as per the latest filing. Also very interesting. Gotta think they plan on utilizing the shell at some point.
Mark out
Thank you for your response. Your feedback is always appreciated and greatly respected.
Mark out